Search results for "Cirrhosis"
Higher MAP linked with AKI reversal among hospitalized patients
A 5 mm Hg increase in mean arterial pressure (MAP) was linked with a small but significant increase in the likelihood of reversal of acute kidney injury (AKI), according to a retrospective study of patients hospitalized with decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2024/04/26/2.htm
26 Apr 2024
Tranexamic acid may help with upper GI bleeding after esophageal variceal ligation
Tranexamic acid significantly reduced upper GI bleeding after esophageal variceal ligation, but mortality rates were similar to those with placebo, a trial in India found.
https://gastroenterology.acponline.org/archives/2024/03/22/3.htm
22 Mar 2024
Undiagnosed liver disease frequently found among patients with cognitive impairment
Among 177,422 veterans with dementia and no prior cirrhosis diagnosis, 10.3% had a Fibrosis-4 score suggestive of advanced fibrosis and 5.3% had a score suggestive of cirrhosis.
https://gastroenterology.acponline.org/archives/2024/02/23/3.htm
23 Feb 2024
Spotlight on cholesterol and the liver
Very low low-density lipoprotein cholesterol levels are associated with increased risk of liver complications in the general population, a European study found, while a study of Chinese patients with primary biliary cholangitis showed that high total cholesterol levels predicted liver disease.
https://gastroenterology.acponline.org/archives/2024/02/23/5.htm
23 Feb 2024
MKSAP quiz: Managing a serous cystadenoma
A 65-year-old woman is evaluated at a follow-up visit. She presented to the emergency department 2 weeks ago with a 2-day history of left-lower-quadrant abdominal pain. The radiology report shows a pancreatic cyst with all the imaging features of a serous cystadenoma. What is the most appropriate management?
https://gastroenterology.acponline.org/archives/2024/02/23/4.htm
23 Feb 2024
Serum ferritin values may improve risk stratification of MASLD patients
Baseline hyperferritinemia occurred in almost one-third of study patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and was associated with higher stages of fibrosis.
https://gastroenterology.acponline.org/archives/2024/01/26/3.htm
26 Jan 2024
Fenofibrate may augment treatment for primary biliary cholangitis
Adding fenofibrate to ursodeoxycholic acid significantly increased the likelihood of biochemical response and normalization of alkaline phosphatase levels, a small trial in China found.
https://gastroenterology.acponline.org/archives/2023/11/17/3.htm
17 Nov 2023
Spotlight on acute kidney injury in cirrhosis
One recent study quantified the incidence of acute kidney injury (AKI) among patients with cirrhosis undergoing CT with contrast, while a review offered advice on diagnosis, nonpharmacological management, and prevention of AKI in cirrhosis.
https://gastroenterology.acponline.org/archives/2023/10/27/5.htm
27 Oct 2023
Alcohol abstinence not required for direct-acting antivirals to cure HCV, study finds
Restricting access to direct-acting antiviral therapy because of alcohol use creates an unnecessary barrier for patients with hepatitis C virus (HCV) infection, according to the authors of a recent study.
https://gastroenterology.acponline.org/archives/2023/10/27/1.htm
27 Oct 2023
Medications for AUD appear beneficial in patients with cirrhosis
A systematic review and meta-analysis found that medications for alcohol use disorder (AUD) were associated with 32% more abstinence versus placebo or standard treatment in patients with alcohol-induced cirrhosis.
https://gastroenterology.acponline.org/archives/2023/09/22/1.htm
22 Sep 2023